Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_assertion type Assertion NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_head.
- NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_assertion description "[Achondroplasia (ACH), thanatophoric dysplasia (TD) types I and II, hypochondroplasia (HCH), and severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) are all due to activating mutations in the fibroblast growth factor receptor 3 (FGFR3) gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_provenance.
- NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_assertion evidence source_evidence_literature NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_provenance.
- NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_assertion SIO_000772 20034074 NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_provenance.
- NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_assertion wasDerivedFrom befree-20150227 NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_provenance.
- NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_assertion wasGeneratedBy ECO_0000203 NP401287.RAEi6WnTtzHmJVcIj2jRkbjaJ9uXuwEJCy9vfo0qgozSc130_provenance.